HDE supplement
H020007 S417: Activa™ Dystonia Therapy System, Percept TM PC BrainSense TM
FDA HDE supplement · normal 75 day track · Medtronic Neuromodulation
Key facts
| Original HDE | H020007 |
|---|---|
| Supplement number | S417 |
| Supplement type | normal 75 day track |
| Reason for the supplement | change design/components/specifications/material |
| Trade name | Activa™ Dystonia Therapy System, Percept TM PC BrainSense TM |
| Generic name | Implanted subcortical electrical stimulator (motor disorders) |
| Applicant | Medtronic Neuromodulation |
| Product code | MRU |
| Received date | Feb 19, 2026 |
| Decision date | May 20, 2026 |
At a glance
- No Approval order on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About HDE supplements
An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.
Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date: